glp 1 agonist injection Comparing Ozempic, Wegovy and Other GLP-1 Drugs Skyrocketing Popularity Puts GLP-1 Agonists
Description
FDA-approved weight management medications beyond GLP-1 agonists include: Phentermine-topiramate (Qsymia): Combination sympathomimetic and anticonvulsant showing 8-10% weight loss in clinical trials
Phase 2 data showed 24.2% weight loss at 48 weeks with the same dose
The mean BMI of the cohort was 37 kg/m 2
Perioperative aspiration risk GLP-1 RAs delay gastric emptying, a pharmacodynamic effect that contributes to appetite suppression but may increase residual gastric volume during procedures involving deep sedation or general anesthesia
NN80224180 trial investigators
doi: 10.2174/1381612827666210119104721 Epub ahead of print
